68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer

被引:13
|
作者
Aydin, Funda [1 ]
Akcal, Arzu [2 ]
Unal, Betul [3 ]
Goksu, Sema Sezgin [4 ]
Gungor, Firat [5 ]
机构
[1] Akdeniz Univ, Dept Nucl Med, Antalya, Turkey
[2] Akdeniz Univ, Dept Plast Reconstruct & Aesthet Surg, Antalya, Turkey
[3] Akdeniz Univ, Dept Pathol, Antalya, Turkey
[4] Akdeniz Univ, Dept Med Oncol, Antalya, Turkey
[5] Emsey Hosp, Dept Nucl Med, Istanbul, Turkey
关键词
Ga-68-PSMA PET/CT; dermatofibroma; PSMA; GA-68-LABELED PSMA LIGAND; HBED-CC; PET/CT; EXPRESSION; CARCINOMA; DIAGNOSIS;
D O I
10.1097/RLU.0000000000001591
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. 68Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as 68Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent 68Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma. © 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:358 / 360
页数:3
相关论文
共 50 条
  • [21] Will 68Ga-PSMA PET become the New Imaging Standard for Prostate Cancer?
    Duewel, C.
    Eiber, M.
    Maurer, T.
    AKTUELLE UROLOGIE, 2016, 47 (05) : 378 - 382
  • [22] Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases
    Perez, Paola M.
    Hope, Thomas A.
    Behr, Spencer C.
    van Zante, Annemieke
    Small, Eric J.
    Flavell, Robert R.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : E28 - E32
  • [23] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
  • [24] Intense Uptake in Amyloidosis of the Seminal Vesicles on 68Ga-PSMA PET Mimicking Locally Advanced Prostate Cancer
    Stephens, Maximilian
    Kim, David Insoo
    Shepherd, Benjamin
    Gustafson, Sonja
    Thomas, Paul
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) : 147 - 148
  • [25] Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy
    Onal, Cem
    Torun, Nese
    Oymak, Ezgi
    Guler, Ozan C.
    Reyhan, Mehmet
    Yapar, Ali F.
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (06) : 388 - 396
  • [26] Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
    Fanti, Stefano
    Minozzi, Silvia
    Morigi, Joshua James
    Giesel, Frederik
    Ceci, Francesco
    Uprimny, Christian
    Hofman, Michael S.
    Eiber, Matthias
    Schwarzenbock, Sarah
    Castellucci, Paolo
    Bellisario, Cristina
    Chauvie, Stephane
    Bergesio, Fabrizio
    Emmett, Louise
    Haberkorn, Uwe
    Virgolini, Irene
    Schwaiger, Markus
    Hicks, Rodney J.
    Krause, Bernd J.
    Chiti, Arturo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1622 - 1635
  • [27] Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
    Queiroz, Marcelo A.
    Viana, Publio
    Santos, Allan
    Bastos, Diogo
    Etchebehere, Elba
    Cerri, Giovanni
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : E417 - E419
  • [28] Detection of Sarcomatoid Lung Metastasis With 68GA-PSMA PET/CT in a Patient With Prostate Cancer
    Geraldo, Llanos
    Ceci, Francesco
    Uprimny, Christian
    Kendler, Dorota
    Virgolini, Irene
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (05) : 421 - 422
  • [29] 68Ga-DOTATATE and 68Ga-PSMA Uptake in Granulomatous Prostatitis
    Ruan, Dan
    Sun, Long
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : 359 - 361
  • [30] Incidental 68Ga-PSMA Uptake in the Benign Enchondroma-A Rare Finding on 68Ga-PSMA PET/CT
    Singh, Parneet
    Kandula, Keerthana Kiran
    Patel, Ranjan Kumar
    Parida, Girish Kumar
    Agrawal, Kanhaiyalal
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : e525 - e527